Supervised exercise improves strength and physical performance in patients with advanced breast cancer - EurekAlert!
Smartphones can monitor patients with neuromuscular diseases - EurekAlert!
New post-hoc analysis shows patients whose clinicians had access to GeneSight results for depression treatment are more likely to feel better sooner - EurekAlert!
Magnetic field therapy shows promise in mimicking exercise benefits for type 2 diabetes patients with central obesity - EurekAlert!
Tying protein to fraying DNA solves mystery of illness for patients around the world - EurekAlert!
AI “digital twins” help patients make smarter decisions about knee surgery, study finds - EurekAlert!
Precision increases in a project led by Germans Trias using AI to detect early facial changes in patients with acromegaly - EurekAlert!
New genetic marker found to predict severe gout drug reactions in US patients - EurekAlert!
Cutting balloon treatment prior to stent placement comparable to intravascular lithotripsy for patients with calcified coronary artery disease - EurekAlert!
Small study suggests 40Hz sensory stimulation may benefit some Alzheimer’s patients for years - EurekAlert!
Idiopathic hypersomnia is a rare disease of excessive sleepiness, with patients revealing they never feel rested or awake no matter how much sleep they get, in analysis of online posts - EurekAlert!
Trial enrollment and survival disparities among patients with advanced epithelial ovarian carcinoma - EurekAlert!
The Surprising Diet That Helps Type 1 Diabetes Patients Use Less Insulin
The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients - EurekAlert!
Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer - EurekAlert!
Retinal implant restores central vision in patients with advanced AMD, study co-led by Pitt investigator shows - EurekAlert!
New guideline emphasizes conversations about mood, mental health between patients and clinicians - EurekAlert!
ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma - EurekAlert!
ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors - EurekAlert!
ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients - EurekAlert!
